In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...

Millions of Medicaid beneficiaries have limited access to Type 2 diabetes medications that reduce the risk of cardiovascular disease, according to a study published April 22 in Annals of Internal ...

Other diabetes medications, however, were not associated with a change ... and altered blood flow — all of which impact brain ...

According to the researchers, the findings indicated that the two drugs may have neuroprotective effects for people without diabetes and may help slow the rate of cognitive decline in Alzheimer's ...

Other GLP-1 medications include Ozempic, Wegovy, Victoza, Saxenda, all made by Novo Nordisk ... only under specific circumstances, such as for diabetes or heightened heart risk," he wrote.